CTLA4 and breast carcinoma: We determined the kinetics and level of expression of key inhibitory ICs (PD-1, CTLA-4, TIM-3 and LAG-3) and Treg-related markers (FoxP3 and Helios) in CD4+ T cells in the absence or presence of breast cancer cells.